1. Home
  2. AVTX vs KF Comparison

AVTX vs KF Comparison

Compare AVTX & KF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • KF
  • Stock Information
  • Founded
  • AVTX 2011
  • KF 1984
  • Country
  • AVTX United States
  • KF United States
  • Employees
  • AVTX N/A
  • KF N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • KF Investment Managers
  • Sector
  • AVTX Health Care
  • KF Finance
  • Exchange
  • AVTX Nasdaq
  • KF Nasdaq
  • Market Cap
  • AVTX 90.9M
  • KF 93.8M
  • IPO Year
  • AVTX 2015
  • KF N/A
  • Fundamental
  • Price
  • AVTX $9.09
  • KF $19.52
  • Analyst Decision
  • AVTX Strong Buy
  • KF
  • Analyst Count
  • AVTX 4
  • KF 0
  • Target Price
  • AVTX $33.00
  • KF N/A
  • AVG Volume (30 Days)
  • AVTX 141.8K
  • KF 18.4K
  • Earning Date
  • AVTX 11-07-2024
  • KF 01-01-0001
  • Dividend Yield
  • AVTX N/A
  • KF N/A
  • EPS Growth
  • AVTX N/A
  • KF N/A
  • EPS
  • AVTX N/A
  • KF N/A
  • Revenue
  • AVTX $820,000.00
  • KF N/A
  • Revenue This Year
  • AVTX N/A
  • KF N/A
  • Revenue Next Year
  • AVTX N/A
  • KF N/A
  • P/E Ratio
  • AVTX N/A
  • KF N/A
  • Revenue Growth
  • AVTX N/A
  • KF N/A
  • 52 Week Low
  • AVTX $3.95
  • KF $18.30
  • 52 Week High
  • AVTX $34.46
  • KF $25.56
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 37.40
  • KF 39.54
  • Support Level
  • AVTX $9.00
  • KF $19.30
  • Resistance Level
  • AVTX $9.99
  • KF $20.01
  • Average True Range (ATR)
  • AVTX 0.89
  • KF 0.31
  • MACD
  • AVTX -0.01
  • KF 0.01
  • Stochastic Oscillator
  • AVTX 27.07
  • KF 37.61

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About KF Korea Fund Inc. (The) New

Korea Fund Inc is a closed-end, non-diversified management investment company. Its investment objective is to seek long-term capital appreciation through investment in securities, equity securities, of Korean companies. Its portfolio consists of the different sectors such as the auto components, banks, beverages, chemicals, aerospace and defense, insurance, machinery, and others.

Share on Social Networks: